Tatsuyuki Kanamori Selected Research

Tatsuyuki Kanamori Research Topics

4	Seasonal Allergic Rhinitis (Hay Fever) 12/2023 - 07/2021
4	Seizures (Absence Seizure) 11/2023 - 07/2003
3	Poisoning 04/2023 - 01/2021
1	Substance-Related Disorders (Drug Abuse) 07/2023
1	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2023
1	Cadaver (Cadavers) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 04/2015
1	Metrorrhagia (Spotting) 01/2012
1	Anaphylaxis (Anaphylactic Shock) 01/2008
1	Bacterial Infections (Bacterial Infection) 01/2008
1	esophageal and vulval Leiomyomatosis with nephropathy 06/2003

4	Cetirizine (Zyrtec)FDA LinkGeneric 12/2023 - 07/2021
4	epinastine FDA Link 12/2023 - 07/2021
4	fexofenadine (Allegra)FDA LinkGeneric 12/2023 - 07/2021
4	Methamphetamine (Desoxyn)FDA LinkGeneric 11/2023 - 06/2003
3	Fentanyl (Sublimaze)FDA LinkGeneric 04/2023 - 01/2021
3	Loratadine (Alavert)FDA Link 01/2023 - 07/2021
2	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2012 - 06/2003
1	desloratadine (Aerius)FDA LinkGeneric 12/2023
1	Lysergic Acid Diethylamide (LSD)IBA 07/2023
1	zopiclone (Zop)IBA 07/2023
1	Hypnotics and Sedatives (Sedatives)IBA 07/2023
1	isotonitazeneIBA 04/2023
1	etonitazeneIBA 04/2023
1	Chlorpheniramine (Chlorphenamine)FDA LinkGeneric 07/2021
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2019
1	XLR-11IBA 04/2015
1	tartaric acid (tartrate)FDA Link 04/2013
1	phenylacetic acid (phenylacetate)FDA Link 04/2013
1	Indicators and Reagents (Reagents)IBA 04/2013
1	methylamine (methylammonium)IBA 04/2013
1	Complex MixturesIBA 01/2012
1	CarbonIBA 12/2008
1	NitrogenIBA 12/2008
1	Cefoperazone (Cefoperazone Sodium)FDA Link 01/2008
1	Sulbactam FDA LinkGeneric 01/2008
1	Phenylpropanolamine (Dexatrim)FDA Link 06/2003
1	Amphetamine (Amfetamine)FDA LinkGeneric 06/2003
1	Ephedrine FDA LinkGeneric 06/2003
1	norpseudoephedrine (cathine)IBA 06/2003
1	Pseudoephedrine FDA LinkGeneric 06/2003

1	Intravenous Administration 01/2008